Microsoft Signals 190 Billion in 2026 Capital Spending Amid Soaring Memory Costs Telomir Pharmaceuticals TELO Q4 2025 Disappoints EPS 028 Below 007 Views Cerebras Nearly Doubles in Nasdaq Debut Surpasses 100 Billion Market Cap in Blockbuster IPO